Zymeworks and Jazz Pharmaceuticals’ Ziihera Gets Green Light for HER2+ BTC Treatment
Partners Zymeworks Inc. (NASDAQ: ZYME) and Jazz Pharmaceuticals, Inc. have received accelerated approval from the...
SWX: ROP
AbbVie’s Elahere Receives EC Approval for FRα-Positive Ovarian Cancer Treatment
US-based AbbVie (NYSE: ABBV) has announced the European Commission (EC) approval for its antibody drug...
Flare Therapeutics and Roche Enter Strategic Collaboration for Oncology Drug Discovery
US-based Flare Therapeutics Inc., a clinical-stage biotech company specializing in cancer therapies through the use...
Roche to Showcase 40+ Abstracts on Blood Disorders at ASH Annual Meeting
Swiss pharmaceutical giant Roche (SWX: ROG) has announced plans to present over 40 abstracts across...
AstraZeneca’s China President Leon Wang Confirmed to Assist in Investigation Amid Fraud Allegations
On October 29, 2024, just hours after celebrating a business school anniversary on social media,...
AstraZeneca China President Leon Wang Involved in Chinese Investigation Amid Industry Probes
Leon Wang, Executive Vice President International and AstraZeneca (AZ, NASDAQ: AZN) China President, is cooperating...
Roche’s Vabysmo Receives NMPA Approval for Macular Edema Treatments in China
Roche (SWX: ROG), the Swiss pharmaceutical giant, has announced the receipt of another marketing approval...
Roche’s Genentech Scores FDA Approval for Itovebi in Advanced Breast Cancer Treatment, Advancing Personalized Oncology
Roche (SWX: ROG)’s Genentech, a leader in pharmaceutical innovation, has received approval from the US...
Roche’s VENTANA CLDN18 Assay Receives EU Approval, Enhances Targeted Therapy Options for Gastric Cancer
Roche (SWX: ROG; OTCMKTS: RHHBY) has secured CE Mark approval in the European Union for...
Regor Therapeutics Strikes Deal with Genentech for CDK Inhibitors, Fetching USD 850 Million Upfront
Regor Therapeutics Group, a US-based biotech with significant ties to China, has entered into a...
Roche’s Xofluza Receives FDA Approval for Reducing Influenza Transmission in Phase III Study
Roche (SWX: ROG; OTCMKTS: RHHBY) has announced that its antiviral drug Xofluza (baloxavir marboxil) has...
Roche’s Tecentriq Hybreza Becomes First Subcutaneous Anti-PD-(L)1 Immunotherapy in the US
Roche (SWX: ROG; OTCMKTS: RHHBY) , a leading Swiss pharmaceutical company, has secured US Food...
Roche’s Ocrevus Zunovo Receives FDA Nod as First Twice-Yearly MS Treatment
Roche Group (SWX: ROG; OTCMKTS: RHHBY) , a Swiss pharmaceutical giant, has announced that the...
Roche’s Columvi for Relapsed DLBCL Gets Review Nod from China’s CDE for New Indication
The Center for Drug Evaluation (CDE) in China has accepted for review an additional indication...
Roche’s Alzheimer’s Disease Diagnostic Kits Gain Approval in Hainan, Set for Use in Shanghai Ruijin Hospital
Swiss pharmaceutical and diagnostics giant Roche (SWX: ROG) has received approval from the Hainan Medical...
Roche Completes Acquisition of LumiraDx’s Point-of-Care Solutions Business
Swiss pharmaceutical and diagnostics giant Roche (SWX: ROG, OTCMKTS: RHHBY, SWX: RO) has announced the...
Roche’s H1’24 Financials Show 5% Growth, Eye Care and Cancer Therapies Drive Sales
Roche (SWX: ROG, OTCMKTS: RHHBY, SWX: RO), the Swiss pharmaceutical and diagnostics giant, has reported...
Roche’s Tiragolumab Misses Primary Endpoints in NSCLC Trial, Study Halted
Roche (SWX: ROG; SWX: RO; OTCMKTS: RHHBY), the Swiss pharmaceutical giant, has announced that a...
Roche Secures RNA Exon Editing Tech for Neurological Diseases with Ascidian Deal
Roche (SWX: ROG; OTCMKTS: RHHBY), a Swiss pharmaceutical giant, is expanding its footprint in the...
Roche’s Genentech Gets Green Light for Vixarelimab UC Clinical Trial in China
Roche (SWX: ROG)’s Genentech, a leading biotechnology company based in Switzerland, has received approval to...